Rare and Urgent Diseases
There is nothing like rare disease research
We meet the challenges of rare disease studies head on – aligning the patient journey with our partners’ goals – building a robust strategy to move these programs forward.
Marc Gas Ph.D., Associate Director, Program Development
Every clinical trial is a challenge, no matter the therapeutic area. But trials in rare and urgent diseases are especially difficult due to the sparsity of the patient population, knowledge gaps in the research community, and a lack of study funding, among other difficulties.
Our rare and urgent disease experience
Biorasi’s speed and agility make the difference overcoming common obstacles in rare disease clinical trials: